Real-world experience with abiraterone

被引：1
|
作者：
Dahut, William L. [1 ]
Madan, Ravi A. [1 ]
机构：
[1] NCI, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 11期
关键词：
METASTATIC PROSTATE-CANCER; INCREASED SURVIVAL; CLINICAL ACTIVITY; ENZALUTAMIDE; CHEMOTHERAPY; RESISTANCE; DOCETAXEL;
D O I：
10.1016/S1470-2045(14)70463-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1188 / 1190
页数：4
相关论文
共 50 条
  • [1] Safety of abiraterone and enzalutamidein French real-world experience
    Scailteux, Lucie-Marie
    Despas, Fabien
    Kerbrat, Sandrine
    Campillo-Gimenez, Boris
    Mathieu, Romain
    Vincendeau, Sebastien
    Balusson, Frederic
    Balusson, Andre
    Nowak, Emmanuel
    Oger, Emmanuel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 466 - 466
  • [2] Real-world experience with abiraterone (vol 15, pg 1188, 2014)
    Dahut, W. L.
    Madan, R. A.
    LANCET ONCOLOGY, 2014, 15 (12): : E528 - E528
  • [3] REAL-WORLD EVIDENCE ON THE UTILISATION OF ABIRATERONE AND ENZALUTAMIDE IN IRELAND
    Trela-Larsen, L.
    Usher, C.
    McCullagh, L.
    Barry, M.
    Walsh, C.
    VALUE IN HEALTH, 2019, 22 : S534 - S534
  • [4] Real world clinical experience with Abiraterone Acetate: The Singapore experience
    Chan, J.
    Loh, K. Y.
    Fong, Y. C.
    Wong, A.
    Chong, K. T.
    Ng, Q. S.
    Toh, C. K.
    Chow, M.
    Rajasekaran, T.
    Kanesvaran, R.
    BJU INTERNATIONAL, 2018, 122 : 43 - 43
  • [5] Real-World Experience with Ofatumumab
    Thomas, K.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 202 - 203
  • [6] Real-world experience - Reply
    Hutchinson, D
    CHEMICAL ENGINEERING PROGRESS, 1998, 94 (03) : 8 - 8
  • [7] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 70
  • [8] Real-world experience with ocrelizumab
    Moss, B.
    Parrotta, E.
    Baldassari, L.
    Planchon, S.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 780 - 781
  • [9] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 31 - 31
  • [10] Ocrelizumab real-world experience
    Moss, B.
    Utigard, E.
    Baldassari, L.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 504 - 505
12345